For maintenance hemodialysis (MHD) patients, the blood is in low hypercoagulable state due to the use of heparin or low molecular weight heparin during dialysis. It is not rare to see hematoma in the puncture site. In recent years, several cases have been reported of spontaneous kidney rupture, but no hip hematoma, let alone both occurred in succession. There was one MHD patient with spontaneous kidney bleeding and hip hematoma in our hospital in 2014, and we provided effective treatment and follow-up.

Keywords:
Hemodialysis, Spontaneous renal subcapsular hematoma, Hip hematoma
1.
Talalla A, Halbrook H, Barbour BH, Kurze T: Subdural hematoma associated with long-term hemodialysis for chronic renal disease. JAMA 1970;212:1847-1849.
2.
Wang IK, Lin CL, Wu YY, Kuo HL, Lin SY, Chang CT, Yen TH, Chuang FR, Cheng YK, Huang CC, Sung FC: Subdural hematoma in patients with end-stage renal disease receiving hemodialysis. Eur J Neurol 2014;21:894-900.
3.
Otsuki H, Ito K, Kosaka T, Hamada S, Takahashi M, Isono M: [Hemodialysis case in which RCC was identified after disappearance of perirenal hematoma following spontaneous renal rupture treated by transcatheter arterial embolization]. Hinyokika Kiyo 2011;57:247-250.
4.
Kumar V, Mallikarjuna HM, Gokulnath: A miniseries of spontaneous intramural esophageal hematoma in hemodialysis patients: a rare cause of dysphagia. Hemodial Int 2014;18:558-561.
5.
Yun S, Cho S, Kim Z, Chong HU, Kim JJ: Surgical management of left upper quadrant sided rectus sheath hematoma occurred by coughing in a hemodialysis patient. Int Surg 2015;100:190-192.
6.
Lin WC, Lin CH: The role of interventional radiology for pediatric blunt renal trauma. Ital J Pediatr 2015;41:76.
7.
Goluza E, Topalović MG, Hudolin T, Konosić S, Kocman IB, Perić M: [Disorders of hemostasis in chronic renal failure and renal transplantation]. Acta Med Croatica 2011;65:337-347.
8.
Zhang J, Li Y, Zhou Y: Relationship between renin-angiotensin-aldosterone system and changes of structure and function in left ven-tricle in maintenance hemodialysis patients. Chin J Blood Purif 2008;7:75-77.
9.
Ying-hui Z: Risk factors in maintenance hemodialysis patients combined with gastrointestinal bleeding. Clin Focus 2015;30:71-74.
10.
Kosmadakis G, Aguilera D, Carceles O, Da Costa Correia E, Boletis I: Pulmonary hypertension in dialysis patients. Ren Fail 2013;35:514-520.
11.
Kahvecioglu S, Ersoy A, Akdag I, Vuruskan H, Calisir B: Spontaneous perirenal hematoma with AA amyloidosis in a hemodialysis patient after unilateral nephrectomy. Amyloid 2008;15:65-68.
12.
Cavoli GL, Bono L, Tortorici C, Ferrantelli A, Giammarresi C, Lorenzo ID, Rotolo U: Spontaneous kidney rupture in a patient on chronic hemodialysis. Indian J Nephrol 2012;22:145-146.
13.
Lai S, Barbano B, Cianci R, Gigante A: [The risk of bleeding associated with low molecular weight heparin in patients with renal failure]. G Ital Nefrol 2010;27:649-654.
14.
Kutsogiannis DJ, Gibney RT, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367.
15.
Treschan TA, Schaefer MS, Geib J, Bahlmann A: Argatroban versus lepirudin in critically ill patients (ALicia): a randomized controlled trial. Crit Care 2014;18:588.
16.
Cao FF, Zhang HT, Feng X, Jiao RN: [Meta-analysis of the role of argatroban in renal replacement therapy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2013;35:667-671.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.